Cargando…

Apolipoprotein D Transgenic Mice Develop Hepatic Steatosis through Activation of PPARγ and Fatty Acid Uptake

Transgenic mice (Tg) overexpressing human apolipoprotein D (H-apoD) in the brain are resistant to neurodegeneration. Despite the use of a neuron-specific promoter to generate the Tg mice, they expressed significant levels of H-apoD in both plasma and liver and they slowly develop hepatic steatosis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labrie, Marilyne, Lalonde, Simon, Najyb, Ouafa, Thiery, Maxime, Daneault, Caroline, Des Rosiers, Chrisitne, Rassart, Eric, Mounier, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470830/ https://www.ncbi.nlm.nih.gov/pubmed/26083030 http://dx.doi.org/10.1371/journal.pone.0130230

Ejemplares similares

Apolipoprotein D Overexpression Protects Against Kainate-Induced Neurotoxicity in Mice
por: Najyb, Ouafa, et al.
Publicado: (2016)

Apolipoprotein D deficiency is associated to high bone turnover, low bone mass and impaired osteoblastic function in aged female mice
por: Martineau, Corine, et al.
Publicado: (2016)

Binding and Repressive Activities of Apolipoprotein E3 and E4 Isoforms on the Human ApoD Promoter
por: Levros, Louis-Charles, et al.
Publicado: (2013)

Apolipoprotein D in Oxidative Stress and Inflammation
por: Fyfe-Desmarais, Guillaume, et al.
Publicado: (2023)

Ochratoxin A Induces Steatosis via PPARγ-CD36 Axis
por: Zheng, Qian-Wen, et al.
Publicado: (2021)

Cerebral Apolipoprotein D Exits the Brain and Accumulates in Peripheral Tissues
por: Desmarais, Frederik, et al.
Publicado: (2021)

Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice
por: Zhang, Yu, et al.
Publicado: (2014)

Non-proteolytic ubiquitin modification of PPARγ by Smurf1 protects the liver from steatosis
por: Zhu, Kun, et al.
Publicado: (2018)

Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis
por: Yu, Jung Hwan, et al.
Publicado: (2016)

PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway
por: Liu, Yu, et al.
Publicado: (2017)

Liver-Specific Deletion of Mouse CTCF Leads to Hepatic Steatosis via Augmented PPARγ Signaling
por: Choi, Yeeun, et al.
Publicado: (2021)

Altered FoxO1 and PPARγ interaction in age-related ER stress-induced hepatic steatosis
por: Kim, Dae Hyun, et al.
Publicado: (2019)

Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγ
por: Zhang, Yang, et al.
Publicado: (2021)

Molecular Modelling Study of the PPARγ Receptor in Relation to the Mode of Action/Adverse Outcome Pathway Framework for Liver Steatosis
por: Tsakovska, Ivanka, et al.
Publicado: (2014)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
por: Garbacz, Wojciech G., et al.
Publicado: (2015)

Hypoxic Jumbo Spheroids On-A-Chip (HOnAChip): Insights into Treatment Efficacy
por: Refet-Mollof, Elena, et al.
Publicado: (2021)

Modulation of liver steatosis by miR-21/PPARα
por: Rodrigues, Pedro M., et al.
Publicado: (2018)

Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
por: Omanovic Kolaric, Tea, et al.
Publicado: (2022)

The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice
por: Stachowicz, Aneta, et al.
Publicado: (2019)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2
por: Kim, Ji-Hyun, et al.
Publicado: (2018)

Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression
por: Li, Lu, et al.
Publicado: (2019)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Modulation of Apolipoprotein D levels in human pregnancy and association with gestational weight gain
por: Do Carmo, Sonia, et al.
Publicado: (2009)

Potent PPARγ Ligands from Swietenia macrophylla Are Capable of Stimulating Glucose Uptake in Muscle Cells
por: Lau, Wai Kwan, et al.
Publicado: (2015)

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis
por: Brusotti, Gloria, et al.
Publicado: (2017)

circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling
por: Guo, Xing-Ya, et al.
Publicado: (2018)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Dietary saturated fat and docosahexaenoic acid differentially effect cardiac mitochondrial phospholipid fatty acyl composition and Ca(2+) uptake, without altering permeability transition or left ventricular function
por: O'Connell, Kelly A, et al.
Publicado: (2013)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population
por: HAI, Bo, et al.
Publicado: (2014)

A novel specific peroxisome proliferator‐activated receptor γ (PPARγ) modulator YR4‐42 ameliorates hyperglycaemia and dyslipidaemia and hepatic steatosis in diet‐induced obese mice
por: Huan, Yi, et al.
Publicado: (2019)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_hkh3903uqu6q43uh11ss5133rh